Mangoceuticals, Inc.
MGRX$0.27
$-0.28 (-51.13%)
OpenLoading chart...
IndexN/A
Market Cap0.00B
Enterprise Value0.01B
Income$-0.00B
Sales$0.00B
EmployeesN/A
P/E-0.20
P/S16.34
P/B0.49
P/C-1.27
EV/EBITDA-0.33
EV/SalesN/A
EPS (ttm)-1.35
EarningsN/A
Gross Margin54.91%
Oper. Margin-4200.46%
Profit Margin-4526.86%
Volume12.40M
Shs Outstand0.01B
Change-51.13%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
Today10:35AMNuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor(newsfilecorp.com)07:00AMMangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology(globenewswire.com)
Feb 2003:40PMMangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?(benzinga.com)09:59AMMangoceuticals Stock Surges On Early Success Of Subscription TRT Model(benzinga.com)
Dec 1910:38AMMangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements(globenewswire.com)07:30AMMangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy(globenewswire.com)
Nov 1307:37PMMangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs(globenewswire.com)02:04PMNovo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs(reuters.com)07:15AMMangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs(reuters.com)
Apr 2510:26AMArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector(newsfilecorp.com)09:00AMMangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division(globenewswire.com)
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
JOHNSTON EUGENE M
Sell
10.0K
$1.13
$11K
Dec 5, 25
Hamilton Alex P.
Sell
125.0K
$1.22
$153K
Nov 19, 25
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $615.87K | $731.49K | $8.94K | N/A |
| Cost of Revenue | $235.91K | $299.99K | $4.09K | N/A |
| Gross Profit | $379.96K | $431.50K | $4.85K | N/A |
| Gross Margin | 61.70% | 58.99% | 54.26% | 0.00% |
| Operating Expenses | $8.35M | $9.65M | $2.00M | $17.52K |
| Operating Income | $-7.97M | $-9.22M | $-1.99M | $-17.52K |
| Operating Margin | -1294.42% | -1260.28% | -22279.70% | 0.00% |
| Net Income | $-8.71M | $-9.21M | $-2.00M | $-17.70K |
| Net Margin | -1413.60% | -1259.40% | -22352.11% | 0.00% |
| EPS (Basic) | $-4.40 | $-8.58 | $-1.73 | $-0.02 |
| EBITDA | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A |
Discover more
You may be interested in